research use only

Allicin Fungal inhibitor

Cat.No.S3860

Allicin (Diallyl Thiosulfinate), the main biologically active component of the freshly crushed garlic extracts, possesses various biological activities including antibacterial, antifungal and antiparasitic effects., Allicin (Diallyl Thiosulfinate), the main biologically active component of the freshly crushed garlic extracts, possesses various biological activities including antibacterial, antifungal and antiparasitic effects.
Jump to

Quality Control

Batch: Purity: >97%
97

Solubility

In vitro
Batch:

DMSO : 32 mg/mL (197.2 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 32 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 162.27 Formula

C6H10OS2

Storage (From the date of receipt) 2 years  -20°C  liquid
CAS No. 539-86-6 Download SDF

Read more about storage stability CAS number

Mechanism of Action

In vitro
Allicin is readily permeable through phospholipid membranes aiding its biological activity. It inhibits the growth of cancer cells of murine and human origin. This compound induces the formation of apoptotic bodies, nuclear condensation and a typical DNA ladder in cancer cells. Furthermore, activation of caspases-3, -8 and -9 and cleavage of poly(ADP-ribose) polymerase are induced by this chemical. It is highly reactive with thiol-groups but under certain conditions it also reacts with itself forming further compounds which can also be bioactive, such as vinyl-dithiins, ajoene and polysulfanes. Since this substance is able to oxidize biomolecules such as glutathione or protein cysteine residues under physiological conditions, it fulfils the definition of a Reactive Sulfur Species (RSS). It certainly acts as a “physiological antioxidant” by inducing the cellular “phase II detoxification system”. This agent activates the redox-dependent mammalian transcription factor Nrf-2 the localization of which depends upon the Keap1 protein (Kelch-like ECH1-associated protein), presumably by oxidizing the regulatory cysteine-residues, as demonstrated for the YAP1-transcription factor which is a functional homologue of the Nrf-2 system in yeast. In vitro studies show that it inhibits TNF-α-mediated T cell adhesion to extracellular matrix components and to endothelial cells. It also inhibits TNF-α-mediated intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on human vascular endothelial cells.
In vivo
Allicin has a protective effect on immune-mediated, Con A-induced hepatitis in mice.
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-10-07)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06833125 ENROLLING_BY_INVITATION
Nosocomial Infection
Alexandria University
2025-03-01 PHASE3
NCT04545879 COMPLETED
Atherosclerosis
National Taiwan University Hospital
2019-03-18
NCT00874666 UNKNOWN
Healthy
Silliker, Inc.
2009-04 EARLY_PHASE1
NCT00455416 UNKNOWN
Follicular Lymphoma
Oslo University Hospital
2007-04 PHASE2
NCT00029250 WITHDRAWN
HIV Infections; Hypercholesterolemia; Hypertriglyceridemia; Hyperglycemia
National Center for Complementary and Integrative Health (NCCIH)
2001-11 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.